S

Synektik SA
WSE:SNT

Watchlist Manager
Synektik SA
WSE:SNT
Watchlist
Price: 191 PLN 0.84% Market Closed
Market Cap: 1.6B PLN
Have any thoughts about
Synektik SA?
Write Note

Synektik SA
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Synektik SA
Total Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
S
Synektik SA
WSE:SNT
Total Equity
zł192.1m
CAGR 3-Years
34%
CAGR 5-Years
22%
CAGR 10-Years
13%
E
Europejski Fundusz Energii SA
WSE:EFE
Total Equity
zł9.4m
CAGR 3-Years
-39%
CAGR 5-Years
-24%
CAGR 10-Years
N/A
M
Medapp SA
WSE:MDA
Total Equity
zł24.8m
CAGR 3-Years
3%
CAGR 5-Years
38%
CAGR 10-Years
N/A
No Stocks Found

Synektik SA
Glance View

Market Cap
1.6B PLN
Industry
Health Care

Synektik SA provides medical and information technology solutions. The company is headquartered in Warsaw, Woj. Mazowieckie and currently employs 145 full-time employees. The company went IPO on 2011-08-09. The company produces PACS software which allows running a diagnostic imaging laboratory. The company runs a research laboratory which performs acceptance and specialist tests of X-ray equipment. The firm sells medical equipment and operates a services center for imaging equipment. Synektik SA is a partner of Siemens. On November 28, 2013, the Company raised its stake in Miedzynarodowe Centra Medyczne Inwestycje Sp z o o to 100%.

SNT Intrinsic Value
172.44 PLN
Overvaluation 10%
Intrinsic Value
Price
S

See Also

What is Synektik SA's Total Equity?
Total Equity
192.1m PLN

Based on the financial report for Sep 30, 2024, Synektik SA's Total Equity amounts to 192.1m PLN.

What is Synektik SA's Total Equity growth rate?
Total Equity CAGR 10Y
13%

Over the last year, the Total Equity growth was 43%. The average annual Total Equity growth rates for Synektik SA have been 34% over the past three years , 22% over the past five years , and 13% over the past ten years .

Back to Top